Announcements

December 19, 2023

Genetic Signatures (ASX:GSS) – $6.9m R&D tax incentive received

December 19, 2023

Genetic Signatures (ASX:GSS) – Trading Halt

December 4, 2023

Genetic Signatures (ASX:GSS) – Appendix 3X – Initial Director’s Interest Notice

December 4, 2023

Genetic Signatures (ASX:GSS) – Non Executive Director Appointment – Stephane Chatonsky

November 29, 2023

Genetics Signatures (ASX:GSS)- 2023 AGM Chairman’s Address and CEO Presentation

October 30, 2023

Genetic Signatures (ASX:GSS) – Quarterly update and Appendix 4C

October 27, 2023

Genetics Signatures (ASX:GSS)- 2023 Notice of Annual General Meeting Proxy Form

September 19, 2023

Genetics Signatures (ASX:GSS) – Investor Presentation

View Announcement

September 4, 2023

Genetic Signatures (ASX:GSS) – FDA 510(k) Filing in Preparation for US Commercial Launch

View Announcement

September 4, 2023

Genetic Signatures (ASX:GSS) – FDA 510(k) Application for Gastrointestinal Parasite Detection Kit Submitted

View Announcement